Judges Scientific Regulatory News (JDG)

Judges Scientific plc (the "Company")

7 March 2013

Director/PDMR Shareholding

Judges Scientific plc has today been advised that purchases of Ordinary Shares of 5p each in the Company ('Ordinary Shares') were made on 5 March by the trustees of the Share Incentive Plan ("Trustees") on behalf of two Directors of the Company, as follows:

A total of 11 Ordinary Shares were purchased on behalf of David Cicurel, the Chief Executive Officer of the Company. His resulting interest in the Company is 916,272 Ordinary Shares representing 17.24 per cent. of the issued Ordinary Share capital.

A total of 12 Ordinary Shares were purchased on behalf of Ralph Cohen, the Finance Director of the Company. His resulting interest in the Company is 50,791 Ordinary Shares representing 0.96 per cent. of the issued Ordinary share capital. In addition, he holds options over 43,100 Ordinary Shares under the Company's Share Option Plans.

The purchases by the Trustees were made at a price of 1070.0p per Ordinary Share. Purchases of a further 699 Ordinary Shares were made on the same date and at the same price on behalf of 51 other members of staff under the Plan.

Enquiries:

Judges Scientific plc

David Cicurel, CEO

01342 323 600

Shore Capital

Pascal Keane

Edward Mansfield

020 7408 4090

Cardew Group

Melvyn Marckus

07775 896491